Abstract:BACKGROUND:Diabetes mellitus is characterized by loss or dysfunction of insulin-producing β-cells in the pancreas, resulting in failure of blood glucose regulation and devastating secondary complications. Thus, β-cells are currently the prime target for cell-replacement and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-cell mass and normoglycemia in diabetic patients. Potential strategies include targeting specific β-cell subpopulations to increase proliferation or maturation. Alternatively, transdifferentiation of pancreatic islet cells (e.g. α- or δ-cells), extra-islet cells (acinar and ductal cells), hepatocytes, or intestinal cells into insulin-producing cells might improve glycemic control. To this end, it is crucial to systematically characterize and unravel the transcriptional program of all pancreatic cell types at the molecular level in homeostasis and disease. Furthermore, it is necessary to better determine the underlying mechanisms of β-cell maturation, maintenance, and dysfunction in diabetes, to identify and molecularly profile endocrine subpopulations with regenerative potential, and to translate the findings from mice to man. Recent approaches in single-cell biology started to illuminate heterogeneity and plasticity in the pancreas that might be targeted for β-cell regeneration in diabetic patients.SCOPE OF REVIEW:This review discusses recent literature on single-cell analysis including single-cell RNA sequencing, single-cell mass cytometry, and flow cytometry of pancreatic cell types in the context of mechanisms of endogenous β-cell regeneration. We discuss new findings on the regulation of postnatal β-cell proliferation and maturation. We highlight how single-cell analysis recapitulates described principles of functional β-cell heterogeneity in animal models and adds new knowledge on the extent of β-cell heterogeneity in humans as well as its role in homeostasis and disease. Furthermore, we summarize the findings on cell subpopulations with regenerative potential that might enable the formation of new β-cells in diseased state. Finally, we review new data on the transcriptional program and function of rare pancreatic cell types and their implication in diabetes.MAJOR CONCLUSION:Novel, single-cell technologies offer high molecular resolution of cellular heterogeneity within the pancreas and provide information on processes and factors that govern β-cell homeostasis, proliferation, and maturation. Eventually, these technologies might lead to the characterization of cells with regenerative potential and unravel disease-associated changes in gene expression to identify cellular and molecular targets for therapy.

Advances in basic biology and translation in islet research

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

A Transcriptional Cross Species Map of Pancreatic Islet Cells.

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Chemical Strategies for Pancreatic Β Cell Differentiation, Reprogramming, and Regeneration

The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Recent progress in modeling and treating diabetes using stem cell-derived islets

Heterogeneous endocrine cell composition defines human islet functional phenotypes

The Ailing β-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture

Exploring pancreatic beta-cell subgroups and their connectivity

Update on the transdifferentiation of pancreatic cells into functional beta cells for treating diabetes

Elucidating T cell dynamics and molecular mechanisms in syngeneic and allogeneic islet transplantation through single-cell RNA sequencing

From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes

Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes

Beneficial effects of intercellular interactions between pancreatic islet cells in blood glucose regulation

Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation

A bright future for glucagon and alpha cell biology

Pancreatic islet transplantation: current advances and challenges

The expanding incretin universe: from basic biology to clinical translation